In literature, several potential MNG targets have been revealed through a non-systematic approach: for instance, MNG is reported to inhibit the growth of non-small cell lung cancer by inhibition of microtubule polymerization (Shen et al., 2017) and, recently, tankyrase-2 (TNKS2), casein kinase 2 (CK2) and bromodomain 9 (Brd9) have been pointed out as its possible targets by in silico inverse virtual screening (Di Micco et al., 2018). Here, TNKS2 is linked to non-small cell lung carcinoma.